Focus on Antibiotics – New Challenges and Steps Forward in Discovery and Development, 2nd Edition
Materialtyp:
ArtikelUtgivningsinformation: MDPI - Multidisciplinary Digital Publishing Institute 2025Beskrivning: 1 electronic resource (282 p.)Innehållstyp: - text
- computer
- online resource
- 9783725840274
- 9783725840281
- Reference, Information and Interdisciplinary subjects
- Research and information: general
- COVID-19
- Cannabis sativa
- ESBLs
- HP1043
- Helicobacter pylori
- L. acidophilus
- PLpro
- SARS-CoV-2
- TEM
- Trichoplusia ni cecropin
- ZnONPs
- aminoglycosides
- antibacterial
- antibacterials
- antibiofilm
- antibiotic resistance
- antibiotics
- antifouling
- antimicrobial applications
- antimicrobial mechanisms
- antimicrobial peptide
- antimicrobial resistance
- antimicrobials
- bacteria
- bacterial pathogens
- bacterial resistance
- bactericidal
- bacteriocins
- biological activity
- biosynthesis
- cancer
- cannabichromene (CBC)
- cannabidiol (CBC)
- cannabigerol (CBG)
- characterization
- chemical modification
- co-crystals
- colistin-resistant Escherichia coli
- crystal engineering
- dendrimers
- drug design
- drug discovery
- endocannabinois (ECs)
- essential transcription factor
- five-membered heterocycles
- flavonoids
- gold nanoparticles
- heterocycles
- kanamycin
- lipopolysaccharide
- methicillin-resistant S. aureus (MRSA)
- mode of action
- molecular docking
- multi drug resistant (MDR) bacteria
- multidrug-resistant bacteria
- nano-therapeutics
- nitrogen heterocycles
- oxygen heterocycles
- p-Bth
- p-BthT
Open Access Unrestricted online access star
This Special Issue, "Focus on Antibiotics – New Challenges and Steps Forward in Discovery and Development, 2nd Edition," explores innovative strategies and groundbreaking research to combat antibiotic resistance. Key advancements include enhancing antibacterial drug potency, selectivity, and safety through five-membered heterocycles; using phytocannabinoids like cannabigerol for MRSA biofilm inhibition; employing ZnONPs and AuNPs to combat MDR pathogens; developing Bac10307-AgNPs with potent antibacterial and antioxidant properties; creating fluoroquinolone co-crystals with flavonoids for enhanced antimicrobial activity; synthesizing 6″-deoxykanamycin A analogues to improve activity against resistant Staphylococcus aureus; designing silver nanocomposites with significant antibacterial and antibiofilm activity; utilizing the insect AMP Tricoplusia ni cecropin A for colistin-resistant Escherichia coli with low cytotoxicity; and enhancing antimicrobial and antiviral activity with peptide [des-Cys11,Lys12,Lys13-(p-BthTX-I)2K] derivatives. This Special Issue showcases collaborative efforts to address antibiotic resistance, inspiring further research and development.
Creative Commons Licence cc by cc https://creativecommons.org/licenses/by/4.0/
eng
Freely available e-book